Sphere Medical reports positive trial data for Proxima blood gas analyser

Sphere Medical has announced the results of a clinical study demonstrating the excellent performance of its Proxima miniature in-line blood gas analyser.

Published at the recent International Symposium on Intensive Care and Emergency Medicine, the study included 20 intensive care unit patients with a range of clinical conditions, including trauma, head injury, post-surgical recovery and sepsis.

Patients were monitored using the Proxima patient-dedicated analyser for up to three days, with the results compared to those generated by the Cobas b221 benchtop analyser from Roche.

Results demonstrated a high level of agreement between the two devices, with Sphere's device allowing for close monitoring of critically ill patients without leaving the patient's bedside.

The report concluded: "Proxima is well-suited to enable staff to more closely manage unstable and critically ill patients. This device may be of significant benefit to patients at risk of iatrogenic anaemia, or those being treated in side and isolation rooms."